April 20, 2018
Rose
An FDA advisory panel gave the green light to the drug, which treats epilepsy, and the full agency is expected to give its approval, as well, sometime in June.
from Kaiser Health News https://ift.tt/2J9Le4G
April 20, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: ‘Scary Day’ For Homeless Vets As VA Closes California Shelter; Massachusetts Governor Readying New Health Policy- After Battling Her Breast Cancer, Scientist Works To Give A.I. An Expertise In Reading Mammograms
- Minor Medical Incidents Can Send Assisted Living Facility Residents To The Hospital Because There’s No Doctor On Site. That Could Be Changing.
- Different Takes: Just What Is The GOP’s Substitute For The Health Law?; Destroying The ACA Would Be Political Catastrophe
- Measles Outbreak In New York Intensifies Long-Smoldering Tensions Between Ultra-Orthodox Jewish Community, Secular Society
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment